Published by Michele Maatouk on 7th April 2026
(Sharecast News) - California-based Gilead Sciences said on Tuesday that it has agreed to buy German clinical stage biotechnology group Tubulis for up to $5bn.
URL: http://www.digitallook.com/dl/news/story/35836642/...